New troglitazone derivatives devoid of PPARγ agonist activity display an increased antiproliferative effect in both hormone-dependent and hormone-independent breast cancer cell lines

✍ Scribed by Christelle Colin; Stéphane Salamone; Isabelle Grillier-Vuissoz; Michel Boisbrun; Sandra Kuntz; Julie Lecomte; Yves Chapleur; Stéphane Flament

• Publisher: Springer US
• Year: 2010
• Tongue: English
• Weight: 405 KB
• Volume: 124
• Category: Article
• ISSN: 0167-6806
• DOI: 10.1007/s10549-009-0700-y